Company / Current Assets per Share
Fulcrum Therapeutics, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5642.49
FY2025
5-year range
$3950.40 / $6391.17
FY2021-FY2025
Trend
+39.9%
vs FY2024
Sector context
#3 of 210
Health Care
What the data says
Among 210 Health Care companies, Fulcrum Therapeutics, Inc. is in the top 1% for current assets per share. Current Assets per Share has fluctuated over the past 8 years, ranging from $3950.40 in FY2023 to $58945.90 in FY2018.
Based on SEC 10-K filings.
5642.49 in FY2025 with a 5-year CAGR of +3.7%. Ranks 3rd among 210 companies in Health Care.
Improved from $3950.40 to $5642.49 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +6.9%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
+3206.5% above sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 39.9% year-over-year.
- Ranks #3 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5642.49 | +39.9% |
| FY2024 | $4032.06 | +2.1% |
| FY2023 | $3950.40 | -14.4% |
| FY2022 | $4612.46 | -27.8% |
| FY2021 | $6391.17 | +35.6% |
| FY2020 | $4713.65 | -48.0% |
| FY2019 | $9060.56 | -84.6% |
| FY2018 | $58945.90 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026